The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 452-458.e4 , February 2009

Soybean (Glycine max) allergy in Europe: Gly m 5 (β-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy

  • Thomas Holzhauser, PhD

      Affiliations

    • Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany
    • Corresponding Author InformationReprint requests: Thomas Holzhauser, PhD, Division of Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany.
  • ,
  • Olga Wackermann, MSc

      Affiliations

    • Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany
  • ,
  • Barbara K. Ballmer-Weber, MD

      Affiliations

    • Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
  • ,
  • Carsten Bindslev-Jensen, MD

      Affiliations

    • Allergy Center, Odense University Hospital, Odense, Denmark
  • ,
  • Joseph Scibilia, MD

      Affiliations

    • Allergology and Clinical Immunology Unit, Niguarda Cá Granda Hospital, Department of Medicine, Milan, Italy
  • ,
  • Lorenza Perono-Garoffo, PhD

      Affiliations

    • National Council of Research, Istituto di Science delle Produzioni Alimentari, Italy
  • ,
  • Shigeru Utsumi, PhD

      Affiliations

    • Research Institute for Food Science, Kyoto University, Kyoto, Japan
  • ,
  • Lars K. Poulsen, PhD

      Affiliations

    • Allergy Clinic, National University Hospital, Copenhagen, Denmark
  • ,
  • Stefan Vieths, PhD

      Affiliations

    • Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany

Received 4 June 2008 ,Revised 10 September 2008 ,Accepted 19 September 2008.

  • Image Result

    IgE-immunoblot analysis of a soybean extract. All lanes except for 28 and P were detected with peroxidase mediated chemiluminescence (lane C: buffer control; lane N: nonatopic control serum pool [n =

    IgE-immunoblot analysis of a soybean extract. All lanes except for 28 and P were detected with peroxidase mediated chemiluminescence (lane C: buffer control; lane N: nonatopic control serum pool [n = 3]; lanes 1, 3, 14, 18, 21, 30, and 28: sera from subjects with soybean allergy summarized in Table I; lane 28: patient 28 detected with phosphatase and precipitating dye; lane P: silver-stained total soybean protein).

  • Image Result
    Purity testing of the individual Gly m 5 (β-conglycinin) subunits β (Gly m 5.03), α (Gly m 5.01), and α′ (Gly m 5.02) from natural soybean source in SDS-PAGE and silver staining (lanes β, α, and α′),

    Purity testing of the individual Gly m 5 (β-conglycinin) subunits β (Gly m 5.03), α (Gly m 5.01), and α′ (Gly m 5.02) from natural soybean source in SDS-PAGE and silver staining (lanes β, α, and α′), and verification of the IgE reactivity of all Gly m 5 subunits by immunoblot analysis with selected soy allergic sera (lane C: buffer control; N: nonatopic control serum pool [n = 3]; lanes 5, 14, 18, 19, and 20: subjects with soybean allergy).

  • Image Result
    A, Individual subunits of Gly m 6 by total protein staining of Western blots with Ponceau S (lanes: G1, Gly m 6.01, G2, Gly m 6.02; G3, Gly m 6.03; G4, Gly m 6.04; G5, Gly m 6.05) and verification of

    A, Individual subunits of Gly m 6 by total protein staining of Western blots with Ponceau S (lanes: G1, Gly m 6.01, G2, Gly m 6.02; G3, Gly m 6.03; G4, Gly m 6.04; G5, Gly m 6.05) and verification of IgE-reactivity of all Gly m 6 subunits (double lane) with patient 28 (N: nonatopic serum pool). B, IgE immunoblot analysis of equal amounts (wt/wt) of the Gly m 6 subunits with selected patients' sera (lane C: buffer control; N: nonatopic control serum pool [n = 3]; lanes 1, 12, 14, 19, and 21: subjects with soybean allergy). The arrows indicate the position of the 5 proglycinin subunits according to molecular weight.

 Supported by the 5th Framework Programme: Quality of Life and Management of Living Resources of the European Commission, QLK4-CT-2001-00301, and by the Swiss Federal Office for Education and Science, BBW01.0159-1.

 Disclosure of potential conflict of interest: C. Bindslev-Jensen has served as an expert witness in a patient antihistamine injury case. L. K. Poulsen has served as an expert witness for Novozymes Ltd. S. Vieths is an associate at the Institute for Product Quality Berlin; has received honoraria from Phadia and the Food Allergy Resource and Research Program; has received research support from the European Union, the Germany Research Society, the Research Fund of the German Food Industry, Monsanto Co, and the European Directorate for the Quality of Medicine and Health Care; and has served as a member of the European Academy of Allergy and Clinical Immunology, the International Union of Immunological Diseases, the European Agency for the Evaluation of Medicinal Products, the European Pharmacopoeia Commission, the International Life Sciences Institute Health and Environmental Science Institute, the European Committee for Standardization, and Deutsche Gesellschaft fur Allergie und Klinische Immunologie. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01729-6

doi: 10.1016/j.jaci.2008.09.034

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 452-458.e4 , February 2009